A new system for the administration of insulin multinjective therapy can make people with diabetes easier.
How many decisions do we have to make within a day? How many problems do we have to find a solution and what commitments should we absolutely forget? For People who coexist with insulinoded diabetesto the newspaper mental load the urgency of Remember when to take therapy And the calculations to be carried out To evaluate the correct each time insulin dosage. There is talk of a number of injections ranging from 1,500 to 1,800 per year, an average of four or five per day, essential to maintain blood glucose levels between 70mg/dl and 180 mg/dl (milligrams per deciliter of blood).
A succession of reminders and calculations from which there is no distraction. It can like this come to help technologywith a new system designed to ensure constant monitoring of glucose in the blood e Send notifications To remember the insulin injection and suggest the necessary quantity.
A more smart system for the MDI. The system is called Smart MDI and is designed for the Diabetes management in people in multi-injection insulin therapy. According to estimates, it is an audience of about 500 thousand patients between those who have received diagnosis of type 1 diabetes and those who live with type 2.
In the first case, we are talking about a disease considered autoimmune, derived from an immunological reaction that destroys the beta cells of the pancreas used for the production of insulin. In the second case, however, the cause is an absent or inadequate production of the hormone that guarantees control of blood glucose levels.
How the system works. It is composed of three elements: one smart pen for the administration of insulin, a sensor to be applied on the arm and which must be changed every 7 days and, this is the main novelty, from A smartphone app. The application, developed by Medtronic, is in constant communication with the sensor to receive the data on the glucose monitoring. When there is something to correct or an injection to remember, sends a notification and also suggests the dose to be taken.
The numbers of diabetes in Italy. In Italy there are about 4 million people who received diagnosis of diabetes. In 90-92% of cases it is type 2, on which, however, we intervene first of all with changes in the diet and lifestyle. For type 1, however, it cannot be ignored by periodic and constant integration of insulin.
“The not treated diabetes It is the first cause of blindness of working age, due to the complications to the retina, but also of Terminal renal failureresolvable only with a transplant », explains Professor Dario Pitocco, Director of the UOSD of Diabetology of the University Policlinico Gemelli in Rome, during the press conference to present the new system.
«This pathology also remains the first cause of non -traumatic amputation of the lower limbs And it doubles the risk of a cardiovascular event greater as a heart attack or stroke ».
The micro -infusor remains the Gold Standard. For people with insulin -dependent diabetes, The therapy of election remains the micro -infusorconsidered the Gold Standard also by the most recent guidelines. It is a system consisting of an electronic insulin pump, with an insulin tank that is connected to a flexible plastic catheter, inserted subcute. It is a mechanism entirely automatedalready set to release the desired quantity of drug without any intervention by the patient who must only take care to replace catheter and tank every two or three days.
About the‘80% of the people concernedhowever,, does not resort to microinphusor. «Until 2022, it used this device only 23% of patients, while the average in Western Europe is 45%. Now it seems to be increasing », confirms Pitocco. «In several they reject the micro -infusor for personal, psychological or even clinical reasons and therefore becomes important to have an alternative Which may also act as a first step towards this system, because it helps to become familiar with technology ».
